The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor

被引:0
|
作者
Elkeles, A [1 ]
Juven-Gershon, T [1 ]
Israeli, D [1 ]
Wilder, S [1 ]
Zalcenstein, A [1 ]
Oren, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor gene is mutated in over 50% of human cancers, resulting in inactivation of the wild-type (wt) p53 protein, The most notable biochemical feature of p53 is its ability to act as a sequence-specific transcriptional activator. Through use of the suppression subtractive hybridization differential screening technique, we identified c-fos as a target for transcriptional stimulation by p53 in cells undergoing p53-mediated apoptosis. Overexpression of wt p53 induces c-fos mRNA and protein. Moreover, in vivo induction of c-fos in the thymus following whole-body exposure to ionizing radiation is p53 dependent. p53 responsiveness does not reside in the basal c-fos promoter. Rather, a distinct region within the c-fos gene first intron binds specifically to p53 and confers upon the c-fos promoter the ability to become transcriptionally activated by wt p53, Identification of c-fos as a specific target for transcriptional activation by p53 establishes a direct link between these two pivotal regulatory proteins and raises the possibility that c-fos contributes to some of the biological effects of p53.
引用
收藏
页码:2594 / 2600
页数:7
相关论文
共 50 条
  • [41] Functional interaction between tumor-suppressor p53 and proto-oncogene ets-1 determines the invasive potential of glial tumors
    Todkar, K.
    Hanson, S.
    Schlaffer, S.
    Pawlak, E.
    Tronnier, V.
    Giese, A.
    Kim, E.
    NEURO-ONCOLOGY, 2006, 8 (04) : 318 - 318
  • [42] Effect of Pentoxifylline on Tumor Suppressor and Proto-Oncogene Apoptosis in Sperm
    David T. Maxwell
    John D. Jacobson
    Alan King
    Philip J. Chan
    Journal of Assisted Reproduction and Genetics, 2002, 19 : 279 - 283
  • [43] Effect of pentoxifylline on tumor suppressor and proto-oncogene apoptosis in sperm
    Maxwell, DT
    Jacobson, JD
    King, A
    Chan, PJ
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2002, 19 (06) : 279 - 283
  • [44] CONTROL OF C-FOS AND C-MYC PROTO-ONCOGENE INDUCTION IN RAT-THYROID CELLS IN CULTURE
    ISOZAKI, O
    KOHN, LD
    MOLECULAR ENDOCRINOLOGY, 1987, 1 (11) : 839 - 848
  • [45] Proto-oncogene c-fos change and neuronal degeneration in the hippocampus of patients with Alzheimer's disease.
    Chen, Z
    Bing, L
    FASEB JOURNAL, 1997, 11 (03): : 3636 - 3636
  • [46] STIMULATION OF ADRENAL-MEDULLARY CELLS INVIVO AND INVITRO INDUCES EXPRESSION OF C-FOS PROTO-ONCOGENE
    STACHOWIAK, MK
    SAR, M
    TUOMINEN, RK
    JIANG, HK
    AN, S
    IADAROLA, MJ
    POISNER, AM
    HONG, JS
    ONCOGENE, 1990, 5 (01) : 69 - 73
  • [47] Inhibition of p53 function in tumours that express the Pax3 proto-oncogene
    Underwood, Timothy J.
    Amin, Jay
    Mossadegh, Somayyeh
    Lillycrop, Karen
    Blaydes, Jeremy P.
    CANCER RESEARCH, 2006, 66 (08)
  • [48] The Proto-Oncogene PBF Binds p53 and Is Associated With Prognostic Features in Colorectal Cancer
    Read, Martin L.
    Seed, Robert I.
    Modasia, Bhavika
    Kwan, Perkin P. K.
    Sharma, Neil
    Smith, Vicki E.
    Watkins, Rachel J.
    Bansal, Sukhchain
    Gagliano, Teresa
    Stratford, Anna L.
    Ismail, Tariq
    Wakelam, Michael J. O.
    Kim, Dae S.
    Ward, Stephen T.
    Boelaert, Kristien
    Franklyn, Jayne A.
    Turnell, Andrew S.
    McCabe, Christopher J.
    MOLECULAR CARCINOGENESIS, 2016, 55 (01) : 15 - 26
  • [49] A RAPIDLY INDUCIBLE DNA-BINDING ACTIVITY WHICH BINDS UPSTREAM OF THE C-FOS PROTO-ONCOGENE
    HAYES, TE
    KITCHEN, AM
    COCHRAN, BH
    JOURNAL OF CELLULAR PHYSIOLOGY, 1987, : 63 - 68
  • [50] MAP kinase-independent induction of proto-oncogene c-fos mRNA by hemin in human cells
    Masuya, Y
    Kameshita, I
    Fujisawa, H
    Kohno, H
    Hioki, K
    Tokunaga, R
    Taketani, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (01) : 289 - 295